Scalper1 News
Several IBD 50 drug and tech companies release quarterly earnings results on Thursday: Akorn, Salix Pharmaceuticals and Skyworks Solutions. All three have IBD’s highest possible Composite Rating, a 99, meaning their shares outperform 99% of all stocks in the market as measured by fundamental and technical factors. Those factors include price performance over the past 12 months, sales growth and earnings growth. Generic-drug maker Akorn (AKRX) Scalper1 News
Scalper1 News